These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 32227525)
1. Understanding the disrupting mechanism of the Tau aggregation motif " Moreno-Castillo E; Álvarez-Ginarte YM; Valdés-Tresanco ME; Montero-Cabrera LA; Moreno E; Valiente PA J Mol Recognit; 2020 Sep; 33(9):e2848. PubMed ID: 32227525 [TBL] [Abstract][Full Text] [Related]
2. Phenylthiazolyl-hydrazide and its derivatives are potent inhibitors of tau aggregation and toxicity in vitro and in cells. Pickhardt M; Larbig G; Khlistunova I; Coksezen A; Meyer B; Mandelkow EM; Schmidt B; Mandelkow E Biochemistry; 2007 Sep; 46(35):10016-23. PubMed ID: 17685560 [TBL] [Abstract][Full Text] [Related]
3. Atomistic mechanism of polyphenol amyloid aggregation inhibitors: molecular dynamics study of Curcumin, Exifone, and Myricetin interaction with the segment of tau peptide oligomer. Berhanu WM; Masunov AE J Biomol Struct Dyn; 2015; 33(7):1399-411. PubMed ID: 25093402 [TBL] [Abstract][Full Text] [Related]
4. Disclosing the Mechanism of Spontaneous Aggregation and Template-Induced Misfolding of the Key Hexapeptide (PHF6) of Tau Protein Based on Molecular Dynamics Simulation. Liu H; Zhong H; Liu X; Zhou S; Tan S; Liu H; Yao X ACS Chem Neurosci; 2019 Dec; 10(12):4810-4823. PubMed ID: 31661961 [TBL] [Abstract][Full Text] [Related]
6. Molecular mechanism of tau aggregation induced by anionic and cationic dyes. Lira-De León KI; García-Gutiérrez P; Serratos IN; Palomera-Cárdenas M; Figueroa-Corona Mdel P; Campos-Peña V; Meraz-Ríos MA J Alzheimers Dis; 2013; 35(2):319-34. PubMed ID: 23435411 [TBL] [Abstract][Full Text] [Related]
7. Integrating in vitro and in silico approaches to evaluate the "dual functionality" of palmatine chloride in inhibiting and disassembling Tau-derived VQIVYK peptide fibrils. Haj E; Losev Y; Guru KrishnaKumar V; Pichinuk E; Engel H; Raveh A; Gazit E; Segal D Biochim Biophys Acta Gen Subj; 2018 Jul; 1862(7):1565-1575. PubMed ID: 29634991 [TBL] [Abstract][Full Text] [Related]
8. Mechanistic insights into remodeled Tau-derived PHF6 peptide fibrils by Naphthoquinone-Tryptophan hybrids. KrishnaKumar VG; Paul A; Gazit E; Segal D Sci Rep; 2018 Jan; 8(1):71. PubMed ID: 29311706 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of tau amyloid formation and disruption of its preformed fibrils by Naphthoquinone-Dopamine hybrid. Paul A; Viswanathan GK; Huber A; Arad E; Engel H; Jelinek R; Gazit E; Segal D FEBS J; 2021 Jul; 288(14):4267-4290. PubMed ID: 33523571 [TBL] [Abstract][Full Text] [Related]
10. A soluble oligomer of tau associated with fiber formation analyzed by NMR. Peterson DW; Zhou H; Dahlquist FW; Lew J Biochemistry; 2008 Jul; 47(28):7393-404. PubMed ID: 18558718 [TBL] [Abstract][Full Text] [Related]
11. Potent Tau Aggregation Inhibitor D-Peptides Selected against Tau-Repeat 2 Using Mirror Image Phage Display. Malhis M; Kaniyappan S; Aillaud I; Chandupatla RR; Ramirez LM; Zweckstetter M; Horn AHC; Mandelkow E; Sticht H; Funke SA Chembiochem; 2021 Nov; 22(21):3049-3059. PubMed ID: 34375027 [TBL] [Abstract][Full Text] [Related]
12. CH-π interaction in VQIVYK sequence elucidated by NMR spectroscopy is essential for PHF formation of tau. Sogawa K; Minoura K; In Y; Ishida T; Taniguchi T; Tomoo K Biopolymers; 2014 May; 102(3):288-95. PubMed ID: 24687309 [TBL] [Abstract][Full Text] [Related]
13. Secondary nucleating sequences affect kinetics and thermodynamics of tau aggregation. Moore CL; Huang MH; Robbennolt SA; Voss KR; Combs B; Gamblin TC; Goux WJ Biochemistry; 2011 Dec; 50(50):10876-86. PubMed ID: 22085312 [TBL] [Abstract][Full Text] [Related]
14. Fisetin inhibits tau aggregation by interacting with the protein and preventing the formation of β-strands. Xiao S; Lu Y; Wu Q; Yang J; Chen J; Zhong S; Eliezer D; Tan Q; Wu C Int J Biol Macromol; 2021 May; 178():381-393. PubMed ID: 33662414 [TBL] [Abstract][Full Text] [Related]
15. Interplay between I308 and Y310 residues in the third repeat of microtubule-binding domain is essential for tau filament formation. Naruto K; Minoura K; Okuda R; Taniguchi T; In Y; Ishida T; Tomoo K FEBS Lett; 2010 Oct; 584(19):4233-6. PubMed ID: 20837015 [TBL] [Abstract][Full Text] [Related]
16. Deciphering the Inhibitory Mechanism of Naphthoquinone-Dopamine on the Aggregation of Tau Core Fragments PHF6* and PHF6. Zou Y; Qi B; Tan J; Guan L; Zhang Q; Sun Y; Huang F ACS Chem Neurosci; 2023 Sep; 14(17):3265-3277. PubMed ID: 37585669 [TBL] [Abstract][Full Text] [Related]
17. A theoretical study of polymorphism in VQIVYK fibrils. Yang J; Agnihotri MV; Huseby CJ; Kuret J; Singer SJ Biophys J; 2021 Apr; 120(8):1396-1416. PubMed ID: 33571490 [TBL] [Abstract][Full Text] [Related]
18. Deciphering the Effect of Lysine Acetylation on the Misfolding and Aggregation of Human Tau Fragment Shah SJA; Zhong H; Zhang Q; Liu H Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269542 [TBL] [Abstract][Full Text] [Related]
19. Heparin remodels the microtubule-binding repeat R3 of Tau protein towards fibril-prone conformations. Dong X; Qi R; Qiao Q; Li X; Li F; Wan J; Zhang Q; Wei G Phys Chem Chem Phys; 2021 Sep; 23(36):20406-20418. PubMed ID: 34494046 [TBL] [Abstract][Full Text] [Related]
20. Atomistic Insights into the Inhibitory Mechanism of Tyrosine Phosphorylation against the Aggregation of Human Tau Fragment PHF6. Zou Y; Guan L; Tan J; Qi B; Wang Y; Zhang Q; Sun Y J Phys Chem B; 2023 Jan; 127(1):335-345. PubMed ID: 36594671 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]